VIRTUAL
12th Stem Cell Society Singapore Symposium 2020
jointly organized with the
Japanese Society for Regenerative medicine (JSRM)
|
Date: 9 - 11 December 2020
(All content will be available beyond the conference) Format: Virtual / Online Symposium 
|
The Stem Cell Society Singapore (SCSS) is pleased to announce that our 12th Annual Symposium will be jointly organized with the Japanese Society for Regenerative Medicine (JSRM). We cordially invite you to participate in this year’s Symposium that will be held from 9-11 December 2020. This year's symposium will be held in a virtual format due to the existing social distancing and travel restrictions locally, regionally, and world-wide.
The symposium as in year’s past will bring together local and international thought leaders and stakeholders who share a common interest in both the fundamental properties of stem cells and their applications to model and treat human disease. In developing this year’s program, the Society intends to play its part in showcasing the accelerating, exciting and often interdisciplinary research in stem cells and cell therapy currently being carried out by our Society members as well as other local and global experts.
Although the virtual format limits in-person interactions, the online format on the other hand provides great and novel opportunities for interactive networking, to reach out to new communities, to present content which would be difficult to integrate into a sit-in symposium, and to have access to the content for extended periods of time after the core symposium.
The symposium as in year’s past will bring together local and international thought leaders and stakeholders who share a common interest in both the fundamental properties of stem cells and their applications to model and treat human disease. In developing this year’s program, the Society intends to play its part in showcasing the accelerating, exciting and often interdisciplinary research in stem cells and cell therapy currently being carried out by our Society members as well as other local and global experts.
Although the virtual format limits in-person interactions, the online format on the other hand provides great and novel opportunities for interactive networking, to reach out to new communities, to present content which would be difficult to integrate into a sit-in symposium, and to have access to the content for extended periods of time after the core symposium.
|
Tentative Confirmed Session Topics: Neural Stem Cells and Neurological Disorders Deconstructing and Reconstructing Organogenesis In-vitro Models of Health and Disease |
Advanced Technologies
Costs and Benefits of Cell and Gene Therapies Cell-based Therapies |
Keynote Speaker:
Yoshiki SAWA
Osaka University, Japan
Arturo Alvarez-Buylla
University of California San Francisco, USA
Osaka University, Japan
Arturo Alvarez-Buylla
University of California San Francisco, USA
|
Currently Confirmed Speakers: Antonio BERTOLETTI Duke-NUS, Singapore Christopher BRAVERY Advbiols, UK Winston CHAN Max-Planck Center for Tissue Stem Cell Research & Regenerative Medicine, China Louise CHENG Peter McCallum Cancer Centre, Australia Christine CHEUNG Lee Kong Chian School of Medicine, Singapore Ray DUNN Lee Kong Chian School of Medicine, Singapore Kim Jee GOH Lee Kong Chian School of Medicine, Singapore Javier GOMEZ FERNANDEZ Singapore University of Design & Technology Roger FOO Genome Institute of Singapore William HWANG National Cancer Centre, Singapore Masahiro KINO-OKA Osaka University, Japan Gary KHOO TESSA Therapeutics, Singapore Zeng LI National Neuroscience Institute, Singapore Jonathan LOH Institute of Molecular and Cell Biology, Singapore |
Yin LU
Bioprocessing Technology Institute, Singapore Yo MABUCHI Tokyo Medical and Dental University, Japan Kyosuké MANO The Japanese Society for Regenerative Medicine, Japan Lisa NG Singapore Immunology Network Shi Yan NG Institute of Molecular and Cell Biology, Singapore Hideyuki OKANO Keio University, Japan Derrick ONG National University of Singapore Xinyi SU Institute of Molecular and Cell Biology, Singapore Rica TANAKA Juntendo University, Japan Carol TANG National Neuroscience Institute, Singapore Yuan QIANG Duke-NUS, Singapore Tom WYROBNIK University College London, UK Yun XIA Lee Kong Chian School of Medicine, Singapore Jia ZHANG Novartis Pharmaceuticals Corporation, US |
|
Important Deadlines
Abstract submission closes: 30 October 2020 Submitted abstracts will be selected either for an oral or poster presentation. |
Online Registration closes:
30 November 2020 |
Registration
Registration fees
|
|
Registration fee includes
|
|
Trainees are defined as:
- Students enrolled in a higher education institutions
- Postdoctoral fellows less than 5 years after post-graduation currently working in a training environment such as academic institutions, hospital settings or equivalent
- Employees of commercial organizations or industry are not eligible for the trainee category
Supporters / Sponsors
Please contact symposium@stemcell.org.sg for any queries regarding your organization's participation in the symposium.
Please contact symposium@stemcell.org.sg for any queries regarding your organization's participation in the symposium.
Cancellation Policy
Cancellations may be considered until 15th October 2020. Notification of cancellation must be submitted to SCSS in writing. A cancellation fee of $50 will apply to cancellations received by 15th October 2020. No Refunds will be provided for cancellations received after 15th October 2020.
Please contact symposium@stemcell.org.sg for any queries.
Cancellations may be considered until 15th October 2020. Notification of cancellation must be submitted to SCSS in writing. A cancellation fee of $50 will apply to cancellations received by 15th October 2020. No Refunds will be provided for cancellations received after 15th October 2020.
Please contact symposium@stemcell.org.sg for any queries.
Jointly Organized by:
|
|